Ruprecht, Jacob C.
Waanders, Taylor D.
Rowland, Christopher R.
Nishimuta, James F.
Glass, Katherine A.
Stencel, Jennifer
DeFrate, Louis E.
Guilak, Farshid
Weinberg, J. Brice
McNulty, Amy L.
Funding for this research was provided by:
Lord Foundation
U.S. Department of Health & Human Services | National Institutes of Health (AR074800, AR065527, AG015768, AR073752, AG046927, AR048852, AR073221, AG028716)
Arthritis Foundation
Veterans Affairs Rehabilitation Research Service Merit Review Award
Orthopaedic Research and Education Foundation
Article History
Received: 15 January 2019
Accepted: 24 May 2019
First Online: 18 June 2019
Competing Interests
: F.G. is a founder and shareholder of Cytex Therapeutics, Inc. The other authors declare no competing interests.